Trial intelligence / Profile preview

iPACK Blocks with Adductor Canal Blocks for ACL Reconstruction Analgesia

NCT05498870Phase 4Completed

Sponsor
Medical University of South Carolina
Start
Aug 2022
Primary completion
Jul 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Pain Scores. Started Aug 2022; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05498870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05498870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call